Boston Trust Walden’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$831K Buy
12,036
+6,670
+124% +$460K 0.01% 287
2025
Q1
$373K Hold
5,366
﹤0.01% 333
2024
Q4
$462K Hold
5,366
﹤0.01% 320
2024
Q3
$639K Hold
5,366
﹤0.01% 308
2024
Q2
$766K Hold
5,366
0.01% 292
2024
Q1
$689K Sell
5,366
-13,980
-72% -$1.8M ﹤0.01% 302
2023
Q4
$2M Hold
19,346
0.02% 246
2023
Q3
$1.76M Hold
19,346
0.01% 251
2023
Q2
$1.57M Buy
19,346
+1,000
+5% +$80.9K 0.01% 257
2023
Q1
$1.46M Sell
18,346
-400
-2% -$31.8K 0.01% 255
2022
Q4
$1.27M Sell
18,746
-184
-1% -$12.5K 0.01% 267
2022
Q3
$943K Hold
18,930
0.01% 275
2022
Q2
$1.06M Sell
18,930
-100
-0.5% -$5.57K 0.01% 272
2022
Q1
$1.06M Sell
19,030
-100
-0.5% -$5.55K 0.01% 277
2021
Q4
$1.07M Sell
19,130
-100
-0.5% -$5.6K 0.01% 282
2021
Q3
$923K Buy
19,230
+1,100
+6% +$52.8K 0.01% 287
2021
Q2
$759K Buy
18,130
+250
+1% +$10.5K 0.01% 299
2021
Q1
$603K Buy
17,880
+550
+3% +$18.5K 0.01% 310
2020
Q4
$605K Hold
17,330
0.01% 307
2020
Q3
$602K Hold
17,330
0.01% 304
2020
Q2
$567K Hold
17,330
0.01% 305
2020
Q1
$522K Sell
17,330
-190
-1% -$5.72K 0.01% 302
2019
Q4
$507K Buy
17,520
+2,190
+14% +$63.4K 0.01% 322
2019
Q3
$396K Hold
15,330
0.01% 336
2019
Q2
$391K Hold
15,330
0.01% 339
2019
Q1
$401K Sell
15,330
-70
-0.5% -$1.83K 0.01% 343
2018
Q4
$355K Sell
15,400
-3,350
-18% -$77.2K 0.01% 341
2018
Q3
$442K Hold
18,750
0.01% 339
2018
Q2
$432K Sell
18,750
-900
-5% -$20.7K 0.01% 339
2018
Q1
$484K Buy
19,650
+3,200
+19% +$78.8K 0.01% 335
2017
Q4
$441K Buy
+16,450
New +$441K 0.01% 343
2015
Q3
Sell
-9,700
Closed -$266K 355
2015
Q2
$266K Buy
9,700
+2,200
+29% +$60.3K ﹤0.01% 338
2015
Q1
$200K Buy
+7,500
New +$200K ﹤0.01% 339